225 related articles for article (PubMed ID: 16026277)
1. The role of factor V Leiden in maternal health and the outcome of pregnancy.
Calderwood CJ; Greer IA
Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
[TBL] [Abstract][Full Text] [Related]
2. Thrombophilia in pregnancy.
Tan JY
Ann Acad Med Singap; 2002 May; 31(3):328-34. PubMed ID: 12061293
[TBL] [Abstract][Full Text] [Related]
3. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.
Alfirevic Z; Roberts D; Martlew V
Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):6-14. PubMed ID: 11803092
[TBL] [Abstract][Full Text] [Related]
4. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
Herman M; Djelmis J; Troselj Z; Ivanisević M
Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilia: implications for pregnancy outcome.
Greer IA
Thromb Res; 2003 Jan; 109(2-3):73-81. PubMed ID: 12706634
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilia and adverse pregnancy outcome.
Robertson L; Wu O; Greer I
Curr Opin Obstet Gynecol; 2004 Dec; 16(6):453-8. PubMed ID: 15534439
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden: a review of the literature.
Ament L
J Perinat Neonatal Nurs; 2003; 17(3):190-5. PubMed ID: 12959480
[TBL] [Abstract][Full Text] [Related]
8. The impact of the factor V Leiden mutation on pregnancy.
Spina V; Aleandri V; Morini F
Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
[TBL] [Abstract][Full Text] [Related]
9. The effect of factor V Leiden carriage on maternal and fetal health.
Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?
Franchini M; Lippi G
Semin Thromb Hemost; 2011 Apr; 37(3):275-9. PubMed ID: 21455861
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilias and recurrent pregnancy loss.
Kutteh WH; Triplett DA
Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
[TBL] [Abstract][Full Text] [Related]
12. [Factor V Leiden mutation and pregnancy complications].
Abraitis V; Mongirdiene A; Mockeviciene A
Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
[TBL] [Abstract][Full Text] [Related]
13. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
Dudding TE; Attia J
Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden mutation and its impact on pregnancy complications.
Hammerová L; Chabada J; Drobný J; Bátorová A
Acta Medica (Hradec Kralove); 2011; 54(3):117-21. PubMed ID: 22250481
[TBL] [Abstract][Full Text] [Related]
16. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
17. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
Mazzarella CR; Del Bianco A; Pietropaolo F
Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
[TBL] [Abstract][Full Text] [Related]
18. Maternal and fetal thrombophilia in intrauterine growth restriction in the presence or absence of maternal hypertensive disease.
Pileri P; Franchi F; Cetin I; Mandò C; Antonazzo P; Ibrahim B; Rossi F; Biguzzi E
Reprod Sci; 2010 Sep; 17(9):844-8. PubMed ID: 20601540
[TBL] [Abstract][Full Text] [Related]
19. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
[TBL] [Abstract][Full Text] [Related]
20. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
